Sort
16,300 grants matching “fatty liver disease”
Role of phospho UBC9 in alcohol-associated liver disease
$425,179Maria Lauda Tomasi · Cedars-Sinai Medical Center · R01 · FY2025 · AA
Serotonergic antidepressants as liver tumor preventives
$425,094Kimberley Jane Evason · University Of Utah · R01 · FY2020 · CA
Gene Therapy for dyslipidemias
$425,007Hui Li · University Of Pennsylvania · P01 · FY2009 · HL
Sympathetic circadian dysfunction in obesity-related hepatocarcinogenesis
$424,987Loning None Fu · Baylor College Of Medicine · R01 · FY2023 · CA
Understanding Pathobiology of MASLD in Diabetic African Americans
$424,875Somiranjan Ghosh · Howard University · R21 · FY2025 · MD
Dietary Micronutrients & Weight Loss in Liver Metabolism & Fat Content in Humans
$424,817Elizabeth Jane Parks · Ut Southwestern Medical Center · RL1 · FY2011 · DK
Metabolic Engineering for Improved Liver Function
$424,808Massachusetts General Hospital · R01 · FY2002 · DK
Mechanisms of Lipid Droplet Formation
$424,800Robert V Farese · Sloan-Kettering Inst Can Research · R01 · FY2024 · GM
Mechanisms of Lipid Droplet Formation
$424,800Robert V Farese · Sloan-Kettering Inst Can Research · R01 · FY2023 · GM
Regional fat-re-accumulation following lipectomy in pre- and postmenopausal women
$424,798Rachael E Van Pelt · University Of Colorado Denver · R01 · FY2008 · DK
Soluble epoxide hydrolase: assessment of in vivo activity and regulation by gut microbiota
$424,792Jang H. Youn · University Of Southern California · R01 · FY2021 · HL
Vitamin E Pharmacokinetics And Biomarkers In Normal And Obese Women
$424,762Mark A Levine · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Transforming Growth Factor - Beta Superfamily Signaling in Diabetes and Obesity
$424,564Sushil Rane · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Functional role of Serum Amyloid A in periapical inflammation
$424,527Hajime Sasaki · Ada Forsyth Institute, Inc. · R01 · FY2015 · DE
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$424,509Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK
Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2
$424,509David E Cohen · Brigham And Women'S Hospital · R37 · FY2013 · DK
Ultrasound Elastography for Liver Fibrosis Staging
$424,506Shigao Chen · Mayo Clinic Rochester · R01 · FY2017 · DK
Intergrative Genetics of Metabolic Syndrome Traits
$424,375Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2012 · HL
Intergrative Genetics of Metabolic Syndrome Traits
$424,374Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2010 · HL
Intergrative Genetics of Metabolic Syndrome Traits
$424,374Aldons Jake Lusis · University Of California Los Angeles · P01 · FY2011 · HL
Liver Cancer Therapy by MiR-22 and Its Inducers
$424,374Yu-Jui Yvonne Wan · University Of California At Davis · R01 · FY2020 · CA
Human and Translational Immunology Training Program
$424,278Kevan C Herold · Yale University · T32 · FY2023 · AI
OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE
$424,200Washington University · R01 · FY2005 · DK
Ketone Body Metabolism and Integrated Metabolic Homeostasis
$424,125Peter A Crawford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · DK
MODULATING PHYSIOLOGIC EFFECTS OF PHOSPHOLIPID METABOLISM IN OBESITY AND DIABETES
$423,984Clay F. Semenkovich · Washington University · R01 · FY2015 · DK